Anemia associated with chronic heart failure: current concepts

References

• SpenceRKThe economic burden of anemia in heart failureHeart Fail Clin2010637338320630411
   PubMedGoogle Scholar
• TangWHYeoPSEpidemiology of anemia in heart failureHeart Fail Clin2010627127820630401
   PubMedGoogle Scholar
• BlancBFinchCAHallbergLNutritional anemias. Report of a WHO Scientific GroupWHO Tech Rep Ser19684051
   Google Scholar
• BeutlerEWaalenJThe definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?Blood20061071747175016189263
   PubMed Web of Science ®Google Scholar
• National Kidney FoundationKDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney DiseaseAm J Kidney Dis20065S1S3
   Google Scholar
• LocatelliFAljamaPBaranyPRevised European best practice guidelines for the management of anaemia in patients with chronic renal failureNephrol Dial Transplant200419Ii1–Ii4715206425
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global OutcomesClinical practice guideline for anemia in chronic kidney diseaseKidney Int Suppl20122288291
   Web of Science ®Google Scholar
• GroenveldHFJanuzziJLDammanKAnemia and mortality in patients with heart failure a systematic review and meta-analysisJ Am Coll Radiol200852818827
   Web of Science ®Google Scholar
• AdamsKFJrPattersonJHOrenRMProspective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINAHFP) RegistryAm Heart J200915792693219376323
   PubMed Web of Science ®Google Scholar
• EzekowitzJAMcAlisterFAArmstrongP WAnemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failureCirculation200310722322512538418
   PubMed Web of Science ®Google Scholar
• TannerHMoschovitisGKusterGMThe prevalence of anemia in chronic heart failureInt J Cardiol20028611512112400591
   PubMed Web of Science ®Google Scholar
• KomajdaMAnkerSDCharlesworthAThe impact of new onset anemia on morbidity and mortality in chronic heart failure: results from COMETEur Heart J2006271440144616717081
   PubMed Web of Science ®Google Scholar
• AnandISKuskowskiMARectorTSAnemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFTCirculation20051121121112716103233
   PubMed Web of Science ®Google Scholar
• AndroneASKatzSDLundLHemodilution is common in patients with advanced heart failureCirculation200310722622912538419
   PubMed Web of Science ®Google Scholar
• NanasJNMatsoukaCKarageorgopoulosDEtiology of anemia in patients with advanced heart failureJ Am Cardiol20064824852489
   Web of Science ®Google Scholar
• AllenLAFelkerGMMeharMRValidation and potential mechanisms of red cell distribution width as a prognostic marker of heart failureJ Card Fail20101623023820206898
   PubMed Web of Science ®Google Scholar
• DecWCAnemia and iron deficiency- new therapeutic targets in heart failure?N Engl J Med20093612475247719920053
   PubMed Web of Science ®Google Scholar
• WeissGGoodnoughLTAnemia of chronic diseaseN Engl J Med20053521011102315758012
   PubMed Web of Science ®Google Scholar
• TestaMYehMFanelliRCirculating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease and hypertensionJ Am Coll Cardiol1996289649718837575
   PubMed Web of Science ®Google Scholar
• GanzTHepcidin: a key regulator of iron metabolism and mediator of anemia of inflammationBlood200310278378812663437
   PubMed Web of Science ®Google Scholar
• AnandISAnemia and chronic heart failure: implication and treatment optionsJ Am Coll Cardiol20085250151118687241
   PubMed Web of Science ®Google Scholar
• BolgerA PDoehnerWSharmaRAnaemia in chronic heart failure: the relationship to inflammatory cytokine expression and prognostic importanceCirculation2002106570571
   Web of Science ®Google Scholar
• BalducciLHardyCLLymanGHHemopoietic reserve in the older cancer patient: clinical and economic considerationsCancer Control2000753954711088062
   PubMedGoogle Scholar
• BommerJSaving erythropoietin by administering L-carnitine?Nephrol Dial Transplant1999142819282110570078
   PubMed Web of Science ®Google Scholar
• OpasichCCazzolaMScelsiLBlunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failureEur Heart J2005262232223715987710
   PubMed Web of Science ®Google Scholar
• WestenbrinkBDVisserF WVoorsAAAnaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production but to fluid retention as wellEur Heart J20072816617117158825
   PubMed Web of Science ®Google Scholar
• Le JemtelTHArainSMediators of anemia in chronic heart failureHeart Fail Clin2010628929320630403
   PubMedGoogle Scholar
• Vander MeerPLipsicEWestenbrinkBDLevels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failureCirculation20051121743174716172283
   PubMed Web of Science ®Google Scholar
• BernsteinKEXiaoHDFrenzelKSix truisms concerning ACE and the renin-angiotensin system educed from the genetic analysis of miceCirc Res2005961135114415947253
   PubMed Web of Science ®Google Scholar
• AlexandrakisMGTsirakisGInternational Scholarly Research NetworkHematology2012
   Google Scholar
• IzaksGJWestendorpRGKnookDLThe definition of anemia in older personsJAMA19992811714171710328071
   PubMed Web of Science ®Google Scholar
• PriceEAMehraRHolmesTHSchrierSLAnemia in older persons: etiology and evaluationBlood Cells Mol Dis20114615916521208814
   PubMed Web of Science ®Google Scholar
• TangYDKatzSDAnemia in chronic heart failure. Prevalence, etiology, clinical correlates and treatment optionsCirculation20061132454246116717164
   PubMed Web of Science ®Google Scholar
• GuralnikJMErshlerWBSchrierSLPicozziVJAnemia in the elderly: a public health crisis in hematologyHematology Am Soc Hematol Educ Program200552853216304431
   PubMedGoogle Scholar
• GuralnikJMEisenstaedtRSKleinHGPrevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemiaBlood20041042263226815238427
   PubMed Web of Science ®Google Scholar
• HorwichTBForanowGCHamiltonMAAnemia is associated with symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failureJ Am Coll Cardiol2002391780178612039491
   PubMed Web of Science ®Google Scholar
• KosiborodMCurtisJ PWangYAnemia and outcomes in patients with heart failure: a study from the National Heart Care ProjectArch Intern Med20051652237224416246989
   PubMed Web of Science ®Google Scholar
• GoASYangJAckersonLMHemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure. The Anemia in Chronic Heart Failure: Outcomes and Resources Utilization (ANCHOR) studyCirculation20061132713272316754803
   PubMed Web of Science ®Google Scholar
• NanasJNMatsoukaCKarageorgopoulosDEtiology of anemia in patients with advanced heart failureJ Am Coll Cardiol2006482485248917174186
   PubMed Web of Science ®Google Scholar
• BeckSLRohdeLEClausellNEtiology and management of anemia in patients with heart failure: how much iron is missing?Congest Heart Fail2008142530
   Google Scholar
• CoyneDWKapoianTSukiWFerric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients’ Response to IV Iron with Elevated Ferritin (DRIVE) StudyJ Am Soc Nephrol20071897598417267740
   PubMed Web of Science ®Google Scholar
• AgarwalAKSinghATherapy with erythropoiesis-stimulating agents and renal and non-renal outcomesHeart Fail Clin2010632333220630407
   PubMedGoogle Scholar
• GlaspyJCavillIRole of iron in optimizing responses of anemic cancer patients to erythropoietinOncology19991346147310234700
   PubMed Web of Science ®Google Scholar
• MacDougallICStrategies for iron supplementation: oral versus intravenousKidney Int Suppl199969S61S6610084288
   PubMed Web of Science ®Google Scholar
• PasrichaSRFlecknoe-BrownSCAllenKJDiagnosis and management of iron deficiency anaemia: a clinical updateMed J Aust201019352553221034387
   PubMed Web of Science ®Google Scholar
• Von HaehlingSAnkerMSJankowskaEAAnemia in chronic heart failure: can we treat? What to treat?Heart Fail Rev20121720321021979835
   PubMed Web of Science ®Google Scholar
• AuerbachMBallardHClinical use of intravenous iron: administration, efficacy, and safetyHematol Am Soc Hematol Educ Program2010338347
   PubMed Web of Science ®Google Scholar
• BhandariSBeyond efficacy and safety – the need for convenient and cost-effective iron therapy in health careNephrol Dial Transplant20114i14i19
   Google Scholar
• MacDougallICRossertJCasadevallNA peptide-based erythropoietin receptor agonist for pure red-cell aplasiaN Engl J Med20093611848185519890127
   PubMed Web of Science ®Google Scholar
• BolgerAPBartlettFRPenstonHSIntravenous iron alone for the treatment of anemia in patients with chronic heart failureJ Am Coll Cardiol2006481225122716979010
   PubMed Web of Science ®Google Scholar
• ToblliJELombrañaADuartePDi GenarroFIntravenous iron reduces NT-pro-brain natriuretic peptide in anemia patients with chronic heart failure and renal insufficiencyJ Am Coll Cardiol2007501657166517950147
   PubMed Web of Science ®Google Scholar
• OkonkoDOGrzesloAWitkowskiTEffect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trialJ Am Coll Cardiol20085110311218191732
   PubMed Web of Science ®Google Scholar
• AnkerSDComin ColetJFilippatosGFerric carboxymaltose in patients with heart failure and iron deficiencyw Engl J Med200936124362448
   PubMed Web of Science ®Google Scholar
• AnkerSDColetJCFilippatosGRationale and design of Ferinject assessment in patients with IRon deficiency and chronic heart failure (FAIRHF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemiaEur J Heart Fail2009111084109119875408
   PubMed Web of Science ®Google Scholar
• EschbachJWCurrent concepts of anemia management in chronic renal failure: impact of NKF-DOQISemin Nephrol20002032032910928333
   PubMed Web of Science ®Google Scholar
• KansagaraDDyerEAWEnglanderHFreemanMKagenDTreatment of anemia in patients with heart disease: a systematic reviewVA-ESP Project 05-2252011
   Google Scholar
• DruekeTBLocatelliFClyneNNormalization of hemoglobin level in patients with chronic kidney disease and anemiaN Engl J Med20063552071208417108342
   PubMed Web of Science ®Google Scholar
• SinghAKSzczechLTangKLCorrection of anemia with epoetin alfa in chronic kidney diseaseN Engl J Med20063552085209817108343
   PubMed Web of Science ®Google Scholar
• PfefferMABurdmannEAChenCYAtrial of darbepoetin alfa in type 2 diabetes and chronic kidney diseaseN Engl J Med20093612019203219880844
   PubMed Web of Science ®Google Scholar
• DicatoMVenous thromboembolic events and erythropoiesis stimulating agents: an updateOncologist200813111518458119
   PubMed Web of Science ®Google Scholar
• ManciniDMKatzSDLangCCEffect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failureCirculation200310729429912538431
   PubMed Web of Science ®Google Scholar
• PonikowskiPAnkerSDSzachniewiczJEffect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trialJ Am Coll Cardiol20074975376217306703
   PubMed Web of Science ®Google Scholar
• GhaliJKAnandISAbrahamWTStudy of Anemia in Heart Failure Trial (STAMINA-HeFT) Group. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemiaCirculation200811752653518195176
   PubMed Web of Science ®Google Scholar
• Vander MeerPGroenveldHFJanuzziJLErythropoietin treatment in patients with chronic heart failure: a meta-analysisHeart2009951309131419168472
   PubMed Web of Science ®Google Scholar
• ParissisJTKoureaKPanouFEffects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathyAm Heart J200815575118371487
   PubMed Web of Science ®Google Scholar
• PalazzuoliASilverbergDIovineFErythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemiaAm Heart J2006152109617161060
   PubMed Web of Science ®Google Scholar
• Van VeldhuisenDJDicksteinKCohen-SolalARandomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemiaEur Heart J2007282208221617681958
   PubMed Web of Science ®Google Scholar
• GeislerBPvan DamRMGazelleGSRisk of bias in meta-analysis on erythropoietin-stimulating agents in heart failureHeart2009951278127919605752
   PubMed Web of Science ®Google Scholar
• McMurrayJJAnandISDiazRRED-HF Committees and InvestigatorsDesign of the reduction of events with darbepoetin alfa in heart failure (RED-HF): a phase III, anaemia correction, morbidity-mortality trialEur J Heart Fail20091179580119633103
   PubMed Web of Science ®Google Scholar
• MaurerMSEfficacy of treating anemia in heart failure with a preserved ejection fraction (HFPEF) on ventricular function, exercise capacity and health statusClinicalTrials.gov Identifier: NCT0286182
   Google Scholar
• SilverbergDSWexlerDBlumMThe use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizationsJ Am Coll Cardiol2000351737174410841219
   PubMed Web of Science ®Google Scholar
• SilverbergDSWexlerDShepsDThe effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled studyJ Am Coll Cardiol2001371775178011401110
   PubMed Web of Science ®Google Scholar
• Comín-ColetJRuizSCladellasMRizzoMTorresABrugueraJA pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardiorenal anemia syndrome: influence on neurohormonal activation and clinical outcomesJ Cardiac Fail200915727735
   Web of Science ®Google Scholar